| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.0B | $8.4B | $7.8B | $8.5B | $7.7B | $1.7B | $1.7B | $1.7B |
| Cost of Revenue | $7.1B | $6.6B | $6.1B | $6.4B | $5.9B | $5.3B | $5.3B | $5.4B |
| Gross Profit | $1.9B | $1.8B | $1.7B | $2.1B | $1.9B | $0.3B | $0.4B | $0.4B |
| R&D Expense | — | — | — | — | $0.0B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | $0.6B | $0.6B | $0.6B | $0.6B | $0.6B | $0.5B | $0.6B | $0.5B |
| Operating Income | $1.1B | $1.1B | $1.1B | $1.4B | $1.2B | $0.2B | $0.2B | $0.3B |
| Net Income | $0.8B | $0.8B | $0.8B | $1.0B | $0.8B | $0.1B | $0.1B | $0.2B |
| EPS (Basic) | $8.61 | $8.97 | $8.52 | $11.08 | $8.87 | $1.30 | $1.44 | $2.17 |
| EPS (Diluted) | $8.58 | $8.93 | $8.48 | $11.03 | $8.83 | $1.30 | $1.43 | $2.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $10.7B | $8.8B | $8.7B | $8.0B | $7.8B | $7.4B | $7.2B | $6.6B |
| Current Assets | $3.2B | $3.2B | $3.3B | $2.5B | $2.7B | $2.8B | $2.5B | $2.1B |
| Cash & Equivalents | $0.5B | $0.7B | $0.6B | $0.3B | $0.6B | $1.0B | $0.7B | $0.4B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.0B | $1.0B | $1.3B | $0.9B | $0.9B | $0.8B | $0.7B | $0.7B |
| Stockholders' Equity | $4.6B | $4.4B | $4.0B | $3.7B | $3.6B | $3.2B | $3.1B | $2.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.2B | $1.3B | $1.5B | $1.1B | $1.0B | $1.2B | $1.2B |
| Investing Cash Flow | $-2.6B | $-0.3B | $-0.9B | $-0.8B | $-0.8B | $-0.4B | $-0.5B | $-0.6B |
| Capital Expenditures | $0.8B | $0.7B | $0.5B | $0.8B | $0.6B | $0.4B | $0.4B | $0.6B |
| Financing Cash Flow | $0.9B | $-0.9B | $-0.1B | $-1.0B | $-0.7B | $-0.3B | $-0.3B | $-0.4B |